BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Xu Y, Liu Z, Ren H, Meng Z, Liu K, Liu Z, Yong J, Wang Y, Li X. A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres. European Journal of Pharmaceutics and Biopharmaceutics 2019;144:217-29. [DOI: 10.1016/j.ejpb.2019.09.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Yang L, Wan F, Bera H, Cun D, Rantanen J, Yang M. Quality by design thinking in the development of long-acting injectable PLGA/PLA-based microspheres for peptide and protein drug delivery. Int J Pharm 2020;585:119441. [PMID: 32442645 DOI: 10.1016/j.ijpharm.2020.119441] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
2 Han C, Fang L, Song S, Min W. Polysaccharides-based delivery system for efficient encapsulation and controlled release of food-derived active peptides. Carbohydrate Polymers 2022;291:119580. [DOI: 10.1016/j.carbpol.2022.119580] [Reference Citation Analysis]
3 Zheng J, Sun Y, Long T, Yuan D, Yue S, Zhang N, Yang Z. Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation. Drug Deliv 2022;29:1164-75. [PMID: 35393920 DOI: 10.1080/10717544.2022.2058653] [Reference Citation Analysis]
4 Bhujel R, Maharjan R, Kim NA, Jeong SH. Practical quality attributes of polymeric microparticles with current understanding and future perspectives. Journal of Drug Delivery Science and Technology 2021;64:102608. [DOI: 10.1016/j.jddst.2021.102608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv 2021;28:1397-418. [PMID: 34184949 DOI: 10.1080/10717544.2021.1938756] [Reference Citation Analysis]
6 Oliveira CG, Dalmolin LF, Silva RTC, Lopez RFV, Maia PIS, Moreto JA. PLGA-nanoparticles loaded with a thiosemicarbazone derived palladium( ii ) complex as a potential agent to new formulations for human ovarian carcinoma treatment. New J Chem 2020;44:14928-35. [DOI: 10.1039/d0nj00580k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Badiee P, Maritz MF, Thierry B. Glycogen kinase 3 inhibitor nanoformulation as an alternative strategy to inhibit PD-1 immune checkpoint. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121845] [Reference Citation Analysis]
8 Lin J, Huang J, Wu J, Tang B, Li C, Xiao H. Poly(lactic acid-co-glycolic acid)-based celecoxib extended-release microspheres for the local treatment of traumatic heterotopic ossification. J Biomater Appl 2022;:8853282211056937. [PMID: 35043696 DOI: 10.1177/08853282211056937] [Reference Citation Analysis]
9 Butreddy A, Gaddam RP, Kommineni N, Dudhipala N, Voshavar C. PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery. Int J Mol Sci 2021;22:8884. [PMID: 34445587 DOI: 10.3390/ijms22168884] [Reference Citation Analysis]
10 Tamani F, Bassand C, Hamoudi M, Siepmann F, Siepmann J. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Monolithic dispersions studied at lower temperatures. International Journal of Pharmaceutics 2021;596:120220. [DOI: 10.1016/j.ijpharm.2021.120220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Noh G, Keum T, Bashyal S, Seo J, Shrawani L, Kim JH, Lee S. Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals. J Pharm Investig 2022;52:75-93. [DOI: 10.1007/s40005-021-00549-5] [Reference Citation Analysis]
12 Gou J, Wang S, Li X, Yin T, He H, Zhang Y, Tang X, Xiao W, Wang Z. Reduced In vivo burst release of ginkgolide B microcrystals achieved by polymeric H+ depot. Journal of Drug Delivery Science and Technology 2022;67:102963. [DOI: 10.1016/j.jddst.2021.102963] [Reference Citation Analysis]
13 Abdurahim J, Serra CA, Blanck C, Vauthier M. One-step production of highly monodisperse size-controlled poly(lactic-co-glycolic acid) nanoparticles for the release of a hydrophobic model drug. Journal of Drug Delivery Science and Technology 2022;71:103358. [DOI: 10.1016/j.jddst.2022.103358] [Reference Citation Analysis]
14 Zhou Y, Gaucher C, Fries I, Hobekkaya MA, Martin C, Leonard C, Deschamps F, Sapin-Minet A, Parent M. Challenging development of storable particles for oral delivery of a physiological nitric oxide donor. Nitric Oxide 2020;104-105:1-10. [PMID: 32771473 DOI: 10.1016/j.niox.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Abd-El Hafeez SI, Eleraky NE, Hafez E, Abouelmagd SA. Design and optimization of metformin hydrophobic ion pairs for efficient encapsulation in polymeric drug carriers. Sci Rep 2022;12:5737. [PMID: 35388027 DOI: 10.1038/s41598-022-09384-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]